Yun Yen

2021

In 2021, Yun Yen earned a total compensation of $448.9K as Director at LIXTE BIOTECHNOLOGY HOLDINGS.

Compensation breakdown

Option Awards$427,047
Other$21,833
Total$448,880

Yen received $427K in option awards, accounting for 95% of the total pay in 2021.

Yen also received $21.8K in other compensation.

Rankings

In 2021, Yun Yen's compensation ranked 10,951st out of 12,412 executives tracked by ExecPay. In other words, Yen earned more than 11.8% of executives.

ClassificationRankingPercentile
All
10,951
out of 12,412
12th
Division
Manufacturing
4,825
out of 5,498
12th
Major group
Chemicals And Allied Products
2,161
out of 2,374
9th
Industry group
Drugs
1,922
out of 2,095
8th
Industry
Pharmaceutical Preparations
1,420
out of 1,542
8th
Source: SEC filing on November 4, 2024.

Yen's colleagues

We found five more compensation records of executives who worked with Yun Yen at LIXTE BIOTECHNOLOGY HOLDINGS in 2021.

2021

Gil Schwartzberg

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2021

Regina Brown

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2021

Philip Palmedo

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2021

Stephen Forman

LIXTE BIOTECHNOLOGY HOLDINGS

Director

2021

Winson Ho

LIXTE BIOTECHNOLOGY HOLDINGS

Director

News

In-depth

You may also like